Abstract
Introduction
Racial and ethnic health disparities have become a prominent issue in the national debate about health care in the United States and have been particularly well-documented in cardiovascular disease (CVD), including stroke, coronary heart disease, heart failure, and high blood pressure (1) (2) (3) . Death rates from CVD are higher among blacks and have decreased at a slower rate than among whites, effectively widening the disparity (4) . High blood pressure is the single most important modifiable risk factor for cardiovascular disease, yet blood pressure control is achieved in only one-third of all patients with high blood Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2011/may/10_0070.htm
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pressure (4) (5) (6) (7) (8) . Among patients with regular medical care, only 48.9% of blacks have their blood pressure adequately controlled, compared with 59.7% of whites (4) .
A number of factors are important in achieving adequate control of high blood pressure, including biological, cultural, social, and health care provider and system factors (9) .
Although access to health care has dominated the national debate about the inadequacies of the US health care system, racial and ethnic disparities among patients with similar access to care and similar socioeconomic status are known to exist (5). Previous studies have found higher awareness and treatment of high blood pressure among blacks than among whites, but poorer control; demographics, socioeconomic status, comorbidities, and behavioral risk factors appear to play little role in explaining these racial differences (4, 6) . Among patients receiving care for high blood pressure, provider nonadherence to treatment guidelines or failure to pursue treatment goals aggressively are known to contribute to low attainment of treatment goals for blood pressure. To our knowledge, however, no prior studies have explored the role of clinical practice patterns in racial disparities in blood pressure control.
Medicaid is the largest provider of health insurance for low-income and minority populations in the United States, and Medicaid patients have a disproportionate share of cardiovascular risk factor prevalence, uncontrolled blood pressure, and associated illness and death (10, 11) . We reviewed the charts of a representative sample of adult Medicaid recipients in North Carolina with diagnosed high blood pressure managed in the primary care setting. The objectives of this analysis were to 1) identify differences in blood pressure control between black and white Medicaid recipients with high blood pressure managed in the primary care setting; 2) examine whether these differences could be explained by differences in demographic factors, comorbidities, or provider characteristics; and 3) determine whether black patients with blood pressure above goal had received differential management for high blood pressure compared with that of white patients during the prior year.
Methods

Study population
We used Medicaid administrative data to select a representative sample of North Carolina Medicaid recipients aged 21 years or older with high blood pressure managed in the primary care setting. Recipients were enrolled with Medicaid for at least 11 months from July 1, 2005, through June 30, 2006, and had an office visit with a diagnosis of high blood pressure (ICD9 401xx), excluding pregnancyinduced high blood pressure. We excluded patients who had any office visits with a cardiologist or endocrinologist during this time and those receiving dialysis services for end-stage renal disease. This study was performed as a quality improvement activity of the North Carolina Division of Medical Assistance and was exempted from review by the University of North Carolina Office of Human Research Ethics.
North Carolina had a traditional fee-for-service (FFS) program for Medicaid recipients and 2 managed-care programs during the study period: Carolina ACCESS (CA-I), in which recipients are assigned to a primary care provider (PCP), and ACCESS II (CA-II), which additionally incorporates community-based care management and quality improvement initiatives. PCPs were identified according to administrative assignment for eligible patients in the CA-I and CA-II systems. For FFS patients, the PCP was identified by examining professional services claims submitted during the eligibility year with the following specialty type: general or family medicine, internal medicine, obstetrics and gynecology, pediatrics, federally qualified health center, rural health center, nurse practitioner, or health department. The provider who had submitted the most claims (or the most recent claim in case of a tie) was identified as that patient's PCP. In Medicaid administrative data, "provider" refers to a single physician or a larger practice organization.
To ensure a representative statewide sample and adequate sampling from 8 counties planning a high blood pressure initiative for CA-II enrollees, we used a stratified cluster sampling design and randomly selected PCPs within 4 sampling strata (CA-II patients in pilot counties, CA-II patients in nonpilot counties, CA-I/FFS patients in pilot counties, and CA-I/FFS patients in nonpilot counties). We excluded providers with fewer than 5 eligible patients. A total of 4,046 charts were reviewed from March through July 2007. Of these, we excluded 224 patients from analysis because there was no high blood pressure diagnosis in the chart; 60 patients because they had no office visit after 
Statistical methods
We used the most recent blood pressure measurement available from the patient's medical chart to assess the prevalence of above-goal blood pressure in blacks compared with whites. Next, we examined the bivariate relationships between race and patient and provider characteristics that may influence blood pressure control. To assess potential explanations for racial disparities in blood pressure control, we used logistic regression to calculate odds ratios (ORs) for the association between blood pressure control and race (black vs white) and expected covariates. First, in the step 1 full model, we tested for contributions of patient characteristic variables in predicting blood pressure control, including sex, age, comorbidities, and number of medications. Covariates associated with blood pressure control with a P value less than .10 were included in the final model. In step 2, we added provider characteristics, including PCP specialty, rural versus urban location, number of years of care with current PCP, and number of visits to PCP during the prior year. Covariates associated with blood pressure control with a P value less than .10 were included in the final step 2 model.
To examine the hypothesis that differential treatment patterns may contribute to observed differences in blood pressure control, we analyzed treatment characteristics for the subset of black and white patients with blood pressure above goal. Treatment characteristics included discussion of medication adherence, diet, weight reduction, exercise, sodium restriction, and moderation of alcohol; change in antihypertensive medication regimen in the prior year; and number of antihypertensive drug classes prescribed in combination.
We additionally examined provider response to high blood pressure during office visits within the year before the most recent office visit, up to 5 visits per patient (n =
4,812 visits for blacks, n = 2,931 for whites). For visits with blood pressure above goal, we examined the likelihood that patients had the following care components: 1) documentation of a lifestyle recommendation (any recommendation for medication adherence, diet, weight reduction, exercise, sodium restriction, or moderation of alcohol), 2) change in antihypertensive medication regimen, and 3) a documented plan for follow-up care.
To analyze data, we used SAS versions 9.1 and 9.2 (SAS Institute, Inc, Cary, North Carolina). Weights were applied to correct for the unequal chance of being selected for patient clusters within providers in the 4 sampling strata, and for unit nonresponse. Analyses accounted for the clustering of patients within providers and for stratification. For significance testing, the F-adjusted Rao-Scott χ 2 square and Wald χ 2 square tests were used.
Results
The proportion of patients who had met their blood pressure goal was significantly lower among black patients than white patients (43.6% vs 50.9%, P = .001) ( Table 1) . A greater proportion of blacks were women (74% vs 65%, P < .01), and age distribution was similar. Although the presence of most comorbidities was similar, blacks were less likely to have hyperlipidemia, chronic kidney disease, chronic obstructive pulmonary disease, asthma, or reactive airway disease, and were less likely to smoke. Whites were more likely than blacks to have 8 or more total active medications (56.6% vs 46.6%). Looking specifically at antihypertensive medications, however, nearly half (46.7%) of blacks were on 3 or more antihypertensive drug classes compared with a third (31.3%) of whites. Geographic location, length of time with current PCP, and number of office visits in the prior year did not differ by race.
In step 1 of the logistic regression modeling (Table 2) , when controlling for patient characteristics, blacks were significantly less likely than whites to have their blood pressure controlled (OR = 0.75; 95% confidence interval [CI], 0.61-0.93; P = .009). Inclusion of provider characteristics to the model in step 2 had little additional effect on the association between race and blood pressure control (OR = 0.78; 95% CI, 0.64-0.96; P = .02), and the relationship remained significant. In addition to race, diabetes, weight status, and PCP specialty other than family practice or internal medicine were associated with poor blood pressure control in the final model.
Among patients who had not achieved their blood pressure goal (n = 1,157 blacks and n = 688 whites) (Table 3) , blacks were more likely than whites to have received counseling regarding sodium restriction (12% vs 8.5%, P = .006), whereas other types of lifestyle recommendations (medication adherence, diet, weight reduction, exercise, and moderation of alcohol) did not differ significantly by race. Only 47.4% of black and 47.2% of white patients with blood pressure above goal had any documentation of lifestyle recommendations during the prior year. Use of combination antihypertensive therapy was more common among blacks (P < .001). Blacks were more likely than whites to have had a change of antihypertensive medication regimen during the prior year (46.7% vs 40.4%, P = .02).
A total of 14,583 office visits were reviewed. Blood pressure was elevated during 4,812 (57.2%) office visits during the prior year for blacks, and 2,931 (49.4%) office visits for whites (Table 4) . During office visits with above-goal blood pressure, blacks were significantly more likely than whites to have a documented lifestyle recommendation (medication adherence, diet, weight reduction, exercise, sodium restriction, or moderation of alcohol) (17.6% vs 13.9%, P = .002) and more likely to have any documented intervention (medication change or lifestyle recommendation) (35.7% vs 30.0%, P = .021). There was no significant difference between races in the likelihood of antihypertensive medication change. A follow-up care plan was noted during 64.3% of above-goal visits for blacks and 69.1% of above-goal visits for whites (P = .08). Planned follow-up within 4 weeks was noted for only 27% of these visits for both races.
Discussion
In this statewide sample of Medicaid patients with high blood pressure managed in the primary care setting, blacks were less likely than whites to have their blood pressure controlled. We found that adjusting for observed patient and provider characteristics slightly attenuated the relationship between race and blood pressure control but did not completely explain racial differences.
One strength of this study is that the sample is representative of a statewide Medicaid population with high blood pressure, spanning multiple systems of care and treatment localities. Medicaid recipients are characterized by many factors known to be associated with poor blood pressure control or poor health outcomes, including low
socioeconomic status and higher prevalence of multiple comorbidities (13, 14) . Our findings are consistent with prior observations that racial differences in blood pressure control among treated patients are not explained by socioeconomic factors, nonpharmacological management, health insurance, or comorbidities (3, 4, 6) . Despite health care coverage, access to care, and frequent office visits, an unexplained racial disparity in blood pressure control still exists.
Provider characteristics, and quality and intensity of care have been shown to be significant causes of health disparities (3). Differences in blood pressure control may conceivably be due to less aggressive care patterns in black patients, culturally insensitive care, or other differences in counseling and follow-up (15, 16) . However, in our study, disparities in blood pressure control do not appear to be explained by differential treatment. Among those with blood pressure above goal, blacks were more likely than whites to have received counseling about sodium intake, to have been prescribed 3 or more blood pressure agents in combination, and to have a change of therapy within the prior year. Within each visit with high blood pressure, the likelihood of medication change and planned follow-up did not differ by race, although blacks were more likely than whites to receive a therapeutic lifestyle recommendation.
Lack of appropriately aggressive care, or clinical inertia, has been cited as a cause for suboptimal control of chronic disease risk factors across much of the US health care system (17) . We confirmed considerable evidence of clinical inertia for both black and white patients. Fewer than half of patients with blood pressure above goal had documentation of any lifestyle counseling in the past year. During visits with high blood pressure, medical therapy was changed on only 1 in 5 opportunities. In addition, 28% of black patients and 34% of white patients with uncontrolled blood pressure were treated with fewer than 2 antihypertensive agents, which may not be sufficient to achieve blood pressure goals (18).
We were unable to explore many characteristics of patients, health systems, and environments that may contribute to racial disparities in blood pressure control, including health literacy, medication adherence, and barriers to following therapeutic lifestyle recommendations (19). Racial differences in the metabolic and hormonal pathogenesis of high blood pressure may contribute to the prevalence and severity of high blood pressure among blacks, although differences in socioeconomic conditions, access to care, and health-related knowledge or attitudes are thought to play a larger role (20). Researchers have examined the extent to which perceptions of racial/ethnic discrimination can adversely affect health (21-24). Negative attitudes attributed to discrimination have been linked to adverse physiologic reactions involving blood pressure, and researchers have hypothesized that the chronic triggering of these cardiovascular reactions due to discrimination could lead to the development of high blood pressure (22). These reactions may be caused by various factors, including worry about blood pressure, care-seeking behavior of patients, lack of trust, majority provider behavior toward minority patients, or miscommunication between patients and providers (18,24-27).
This study had several limitations. We may have overestimated blood pressure control in this population because all patients sampled were receiving primary care services, and patients with more complicated disease (those seeing cardiologists and endocrinologists and those on dialysis) were excluded. Our study population had a lower proportion of patients older than 65 years than the source Medicaid population, probably because of these exclusions. Generalizability to other populations is also limited. Medicaid eligibility requires meeting state-specific thresholds of low income and assets, in addition to categorical requirements of being elderly, disabled, or pregnant, or having dependent children. Our analyses were limited to information obtainable in the medical record and relied on the accuracy of clinic blood pressure measurements and completeness of chart documentation, which may be particularly unreliable in assessing the extent of therapeutic lifestyle counseling. We counted as evidence of counseling any mention of lifestyle factors or medication adherence in the visit note.
In summary, the gap between current care and ideal care for both black and white Medicaid recipients with high blood pressure is substantial, even among patients with frequent access to primary care. Racial disparities in blood pressure control are not readily explained by socioeconomic, demographic, or comorbidity differences or by provider characteristics or treatment patterns. Current care patterns are not sufficient to eliminate racial disparities in blood pressure control or to achieve desired treatment goals. The consequences of ineffective health care for high blood pressure, in terms of avoidable cardiovascular illness, death, and health care costs, disproportionately affect blacks. Emerging models of high blood pressure care, incorporating patient-centered care teams and planned, (12) . b Variables with missing data overall and by race are as follows: tobacco use (overall = 1,077, black = 717, and white = 30), chronic kidney disease (eGFR<0) (overall = 332, black = 211, and white = 121), and length of time with current PCP (overall = 107, black = 8, and white = 22). Total n for blacks, 2,078; for whites, 1,3; and overall, 3,1 (no missing data for sex, age group, both blood pressure measures, diabetes, hyperlipidemia, cardiovascular disease, COPD/asthma, provider location, PCP visits in past year). c P value based on F-adjusted Rao-Scott χ 2 test comparing black and white patients. d Weight distribution for those patients for whom both height and weight were documented in the medical chart. For patients without height, median height of the population was used (total n = 3,3; black n = 2,031; white n = 1,12. No weight abstracted for 71 patients). e Tobacco use among those who have been screened for tobacco use and whose status was known (total n = 2,37; black n = 1,31; white n = 1,07). f Chronic kidney disease for those for whom eGFR was available (total n = 3,182; black n = 1,87; white n = 1,31 Abbreviations: CI, confidence interval; BMI, body mass index; GFR, glomerular infiltration rate; COPD, chronic obstructive pulmonary disease; PCP, primary care provider; JNC-7, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressire. a Blood pressure at goal according to JNC-7 standards; <130/80 mm Hg for patients with diabetes; otherwise <10/90 mm Hg (12) . b Variables with missing data overall and by race are as follows: tobacco use (overall = 1,077, black = 717, and white = 30), chronic kidney disease (eGFR<0) (overall = 332, black = 211, and white = 121), and length of time with current PCP (overall = 107, black = 8, and white = 22). Total n for blacks, 2,078; for whites, 1,3; and overall, 3,1 (no missing data for sex, age group, both blood pressure measures, diabetes, hyperlipidemia, cardiovascular disease, COPD/asthma, provider location, PCP visits in past year). c P value based on F-adjusted Rao-Scott χ 2 test comparing black and white patients. d Weight distribution for those patients for whom both height and weight were documented in the medical chart. For patients without height, median height of the population was used (total n = 3,3; black n = 2,031; white n = 1,12. No weight abstracted for 71 patients). e Tobacco use among those who have been screened for tobacco use and whose status was known (total n = 2,37; black n = 1,31; white n = 1,07). f Chronic kidney disease for those for whom eGFR was available (total n = 3,182; black n = 1,87; white n = 1,31). g Providers located in a county with a population density of more than 200 people per square mile, according to US Census 2000 data, were classified as urban; all others were classified as rural. h For 107 patients, no first visit date was abstracted. Therefore, length of care with their provider could not be established. Abbreviations: CI, confidence interval; BMI, body mass index; GFR, glomerular infiltration rate; COPD, chronic obstructive pulmonary disease; PCP, primary care provider; JNC-7, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressire. a Blood pressure at goal according to JNC-7 standards; <130/80 mm Hg for patients with diabetes; otherwise <10/90 mm Hg (12) . b Variables with missing data overall and by race are as follows: tobacco use (overall = 1,077, black = 717, and white = 30), chronic kidney disease (eGFR<0) (overall = 332, black = 211, and white = 121), and length of time with current PCP (overall = 107, black = 8, and white = 22). Total n for blacks, 2,078; for whites, 1,3; and overall, 3,1 (no missing data for sex, age group, both blood pressure measures, diabetes, hyperlipidemia, cardiovascular disease, COPD/asthma, provider location, PCP visits in past year). c P value based on F-adjusted Rao-Scott χ 2 test comparing black and white patients. d Weight distribution for those patients for whom both height and weight were documented in the medical chart. For patients without height, median height of the population was used (total n = 3,3; black n = 2,031; white n = 1,12. No weight abstracted for 71 patients). e Tobacco use among those who have been screened for tobacco use and whose status was known (total n = 2,37; black n = 1,31; white n = 1,07). f Chronic kidney disease for those for whom eGFR was available (total n = 3,182; black n = 1,87; white n = 1,31). g Providers located in a county with a population density of more than 200 people per square mile, according to US Census 2000 data, were classified as urban; all others were classified as rural. h For 107 patients, no first visit date was abstracted. Therefore, length of care with their provider could not be established. c Tobacco use among those who have been screened for tobacco use and whose status was known (total, n = 2,37; black, n = 1,31; white, n = 1,07). d Chronic kidney disease for those for whom eGFR was available (total, n = 3,182; black, n = 1,87; white, n = 1,31). e Providers located in a county with a population density of more than 200 persons per square mile, according to US Census 2000 data, were classified as urban; all others were classified as rural. f For 107 patients, no first visit date was abstracted. Therefore, length of care period with their provider could not be established. c Tobacco use among those who have been screened for tobacco use and whose status was known (total, n = 2,37; black, n = 1,31; white, n = 1,07). d Chronic kidney disease for those for whom eGFR was available (total, n = 3,182; black, n = 1,87; white, n = 1,31). e Providers located in a county with a population density of more than 200 persons per square mile, according to US Census 2000 data, were classified as urban; all others were classified as rural. f For 107 patients, no first visit date was abstracted. Therefore, length of care period with their provider could not be established. 
